|
NIH Grants for Pharmacogenomics Research FY'05
August 15 — September 11 |
||||
|
City, State, or Country Name
|
Organization Name
|
Principal Investigator
|
Award
|
Title
|
| Alabama Birmingham | University of Alabama at Birmingham | Benza, Raymond |
$463,417
|
Pharmacogenomics in Pulmonary Arterial Hypertension |
| California Oakland |
Children's Hospital and Research Center | Krauss, Ronald |
$3,286,210
|
Pharmacogenomics and Risk of Cardiovascular Disease |
| San Francisco | University of California | Kwok, Puiyan |
$20,000
|
7th International SNP Meeting |
| San Francisco | University of California | Benowitz, Neil |
$2,000,000
|
Pharmacogenetics of Nicotine Addiction and Treatment |
| San Francisco | University of California | Miller, Walter |
$54,540
|
Pharmacogenomics of Human P450 Oxidoreductase |
| San Francisco | University of California | Derisi, Joseph |
$884,775
|
Novel Anti-Malarials by Combinatorial Pharmacogenomics |
| Stanford | Stanford University | Altman, Russ |
$2,851,826
|
The PharmGKB: Catalyzing Research in Pharmacogenetics |
| Torrance | Harbor-UCLA Research and Education Center | Adler, Sharon |
$509,561
|
SNP Haplotyping to Detect Diabetic Nephropathy Risk |
| Florida Gainesville |
University of Florida | Johnson, Julie |
$1,614,979
|
Pharmacogenomic Evaluation of Antihypertensive Responses |
| Gainesville | University of Florida | Johnson, Julie |
$835,849
|
Hypertension Pharmacogenetics |
| Jacksonville | Nemours Children's Clinic | Lima, John |
$421,019
|
Pharmacogenetics of Asthma Monotherapy |
| Indiana Indianapolis |
Indiana University-Purdue University | Renbarger, Jamie |
$136,323
|
Pharmacogenetic Determinants of Vinca Alkaloid Response |
| Indianapolis | Indiana University-Purdue University | Flockhart, David |
$140,356
|
Clinical Relevance of Cytochrome P450 Pharmacogenetics |
| Indianapolis | Indiana University-Purdue University | Flockhart, David |
$2,295,626
|
Pharmacogenetics Research Network and Knowledge Base |
| Ioway Decorah | Luther College | Carlson, Scott |
$186,701
|
Cytochrome P450 overexpression and hypertension in SHR |
| Kentucky Louisville |
University of Louisville | Hein, David |
$128,258
|
Pharmacogenetics of drug and carcinogen metabolism |
| Maryland Baltimore |
Johns Hopkins University | Pulver, Ann |
$1,436,911
|
A Genome Wide SNP Association Study: Schizophrenia |
| Massachusetts Boston |
Brigham and Women's Hospital | Weiss, Scott |
$3,361,644
|
Pharmacogenetics of Asthma Treatment |
| Boston | Brigham and Women's Hospital | Reilly, John |
$651,517
|
COPD Exacerbations: Pharmacogenetic Approaches to Thera* |
| Boston | Tufts University | Schaefer, Ernst |
$836,840
|
Pharmacogenetics of the Statin Response |
| Michigan Ann Arbor |
University of Michigan | Burmeister, Margit |
$183,400
|
SNPs in Neurotransmitter Systems & Personality Traits |
| Minnesota Rochester |
Mayo Clinic College of Medicine | Camilleri, Michael |
$258,125
|
Pharmacogenomics of Gastric Function & Weight in Obesity |
| Missouri St. Louis |
Washington University | Gage, Brian |
$723,333
|
Pharmacogenetics, Biomarkers, and Antithrombotic Therapy |
| North Carolina Winston-Salem |
Wake Forest University | Zheng, Siqun |
$71,750
|
Utility of SNP genotyping using pooled DNA samples in a* |
| Pennsylvania Philadelphia |
University of Pennsylvania | Whitehead, Alexander |
$592,603
|
Pharmacogenetics of Methotrexate Therapy in Arthritis |
| Tennessee Nashville |
Vanderbilt University | Roden, Dan |
$2,879,093
|
Pharmacogenomics of Arrhythmia Therapy |
| Virginia Richmond |
Virginia Commonwealth University | Kerns, Robnet |
$33,374
|
Pharmacogenomics of ethanol and myelin gene expression |
| Washington Seattle |
University of Washington | Psaty, Bruce |
$700,395
|
Pharmacogenetics and Cardiovascular Events |
|
*SOURCE: US National Institutes of Health
|
||||
NIH Grants for Pharmacogenomics Research: Sep 22, 2005
Premium